9.48
price up icon11.53%   0.98
 
loading
Precedente Chiudi:
$8.50
Aprire:
$8.49
Volume 24 ore:
1.05M
Relative Volume:
0.25
Capitalizzazione di mercato:
$73.97M
Reddito:
-
Utile/perdita netta:
$-6.42M
Rapporto P/E:
-1.6925
EPS:
-5.6013
Flusso di cassa netto:
$-7.45M
1 W Prestazione:
-33.66%
1M Prestazione:
+334.86%
6M Prestazione:
-37.34%
1 anno Prestazione:
-59.31%
Intervallo 1D:
Value
$8.36
$9.6865
Intervallo di 1 settimana:
Value
$7.13
$14.97
Portata 52W:
Value
$1.80
$25.92

Cervomed Inc Stock (CRVO) Company Profile

Name
Nome
Cervomed Inc
Name
Telefono
(617) 744-4400
Name
Indirizzo
20 PARK PLAZA, BOSTON
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
CRVO's Discussions on Twitter

Confronta CRVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRVO
Cervomed Inc
9.48 73.97M 0 -6.42M -7.45M -5.6013
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Cervomed Inc Stock (CRVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Aggiornamento Chardan Capital Markets Neutral → Buy
2024-12-17 Downgrade H.C. Wainwright Buy → Neutral
2024-12-11 Downgrade Chardan Capital Markets Buy → Neutral
2024-12-11 Downgrade Morgan Stanley Overweight → Underweight
2024-12-10 Downgrade D. Boral Capital Buy → Hold
2024-12-06 Iniziato ROTH MKM Buy
2024-12-05 Iniziato H.C. Wainwright Buy
2024-09-18 Iniziato Chardan Capital Markets Buy
2024-07-26 Iniziato Morgan Stanley Overweight
2024-02-15 Iniziato Canaccord Genuity Buy
2020-11-17 Downgrade H.C. Wainwright Buy → Neutral
2018-03-21 Iniziato H.C. Wainwright Buy
Mostra tutto

Cervomed Inc Borsa (CRVO) Ultime notizie

pulisher
Mar 28, 2025

FY2025 EPS Estimates for CervoMed Lowered by Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

CervoMed (CRVO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

CervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral Capital - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 27, 2025
pulisher
Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

CervoMed Inc. to Present Findings on Neflamapimod in Dementia with Lewy Bodies at AP/PD™ Conference 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

New Clinical Data: CervoMed's Breakthrough Dementia Drug Results Revealed at Global Conference - StockTitan

Mar 25, 2025
pulisher
Mar 22, 2025

CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025
pulisher
Mar 22, 2025

CervoMed Stock: Extension Study Data In Dementia Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Roth Capital Issues Negative Forecast for CervoMed Earnings - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Q1 Earnings Forecast for CervoMed Issued By Roth Capital - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts? - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed reports FY24 EPS ($2.02), consensus ($1.85) - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed Inc (CRVO) Reports Q4 Net Loss of $16.3 Million, Grant Revenue at $9.7 Million - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roth Mkm Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

CervoMed (NASDAQ:CRVO) Given New $21.00 Price Target at Canaccord Genuity Group - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Best Biotech Stocks To Watch Now – March 17th - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025
pulisher
Mar 18, 2025

CervoMed price target raised to $20 from $15 at Roth MKM - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Following A Monumental March, Can CRVO Keep The Rally Going In April? - RTTNews

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed sees cash runway into mid-2026 - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed price target raised to $21 from $12 at Canaccord - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Cervomed Inc. Faces Financial Hurdles Due to Regulatory Restrictions on Public Float - TipRanks

Mar 18, 2025
pulisher
Mar 17, 2025

Small Cap Stocks To Watch NowMarch 13th - MarketBeat

Mar 17, 2025
pulisher
Mar 17, 2025

Peering Into CervoMed's Recent Short Interest - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 -March 17, 2025 at 08:19 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

CervoMed's Breakthrough in Lewy Body Dementia Treatment Shows Promise in Latest Financial Report - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Why CervoMed Inc. (CRVO) Soared Last Week? - Insider Monkey

Mar 17, 2025
pulisher
Mar 16, 2025

These 10 Stocks Posted Double-, Triple-Digit Gains Last Week - Insider Monkey

Mar 16, 2025
pulisher
Mar 16, 2025

Small Cap Stocks To Watch TodayMarch 12th - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

10 Best Short-Term Stocks to Buy Now with Rebound Potential - Insider Monkey

Mar 16, 2025
pulisher
Mar 15, 2025

Capital One, CervoMed, HPE, Eaton, PepsiCo: Trending by Analysts - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (CRVO) Stock: 187% Weekly Surge Catches Analysts’ Attention - MoneyCheck

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (NASDAQ:CRVO) Raised to Buy at Jones Trading - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

Biotech Stocks To Keep An Eye On – March 13th - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

CervoMed (NASDAQ:CRVO) Stock Rating Upgraded by Chardan Capital - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

CervoMed upgraded to Buy at JonesResearch on more confidence in DLB program - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

‘Turning point in dementia’—CervoMed stock skyrockets on promising dementia drug results - InvestorsObserver

Mar 14, 2025
pulisher
Mar 14, 2025

We Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business Growth - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Best Biotech Stocks To Watch Now – March 12th - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

CervoMed (NASDAQ:CRVO) Upgraded at Brookline Capital Management - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Medical Stocks To Keep An Eye On – March 12th - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

FY2024 EPS Forecast for CervoMed Increased by Analyst - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

CervoMed - The Pharma Letter

Mar 13, 2025
pulisher
Mar 13, 2025

CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says - Benzinga India

Mar 13, 2025
pulisher
Mar 13, 2025

Jones Trading lifts CervoMed stock rating, sets $15 target - Investing.com India

Mar 13, 2025

Cervomed Inc Azioni (CRVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
Capitalizzazione:     |  Volume (24 ore):